4/A

FORM 4/A SUBMISSION

Company: Atara Biotherapeutics, Inc.
Filed: March 1, 2019
Period of Report: June 14, 2018
Accession Number: 0001209191-19-014938

View Document ↗ View on SEC.gov ↗